BRCA1 and cancer: Two further retrospective analyses found an association between BRCA1/2 status and higher risk of unfavourable histology, disease recurrence and cancer specific-survival (CSS) with a difference of 8.6 years versus 15.7 years between BRCA1/2 pathogenic variant carriers and non-carriers [49, 50].